Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03908190 · ClinicalTrials.gov registry record · NA
Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic
A NA study, sponsored by Syracuse VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03908190: Completed NA study, sponsored by Syracuse VA Medical Center.
NCT03908190 is a NA study that has completed, run by Syracuse VA Medical Center. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03908190, a NA study, has completed, sponsored by Syracuse VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the Personalized Support for Progress (PSP) intervention in a Veterans Health Administration (VHA) Women's Wellness Clinic. PSP uses a peer support provider to help women identify their primary concern, develop a personalized plan to help address that concern, and provide practical and emotional support to implement the plan. The primary aim is to evaluate the feasibility, acceptability, and utility of PSP and the research protocol.
Primary Outcome
This is an assessment of trial feasibility.
Interventions
- BEHAVIORAL Personalized Support for Progress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2021-03-03 |
| Phase | NA |
What the finished NCT03908190 record still lists
NCT03908190 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Personalized Support for Progress is the first listed.
NCT03908190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03908190 about?
NCT03908190 is a clinical study titled "Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic". The purpose of this study is to evaluate the Personalized Support for Progress (PSP) intervention in a Veterans Health Administration (VHA) Women's Wellness Clinic. PSP uses a peer support provider to help women identify their primary concern, develop a personalized plan to help address that concern...
What is the current status of trial NCT03908190?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-11-13. Estimated completion is 2021-03-03.
What interventions are being tested in trial NCT03908190?
The interventions under investigation include: Personalized Support for Progress (BEHAVIORAL).
Who is sponsoring clinical trial NCT03908190?
This trial is sponsored by Syracuse VA Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03908190's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI